Your browser doesn't support javascript.
loading
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.
Deng, Jinhai; Pan, Teng; Liu, Zaoqu; McCarthy, Caitlin; Vicencio, Jose M; Cao, Lulu; Alfano, Giovanna; Suwaidan, Ali Abdulnabi; Yin, Mingzhu; Beatson, Richard; Ng, Tony.
Affiliation
  • Deng J; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Pan T; Clinical Research Center (CRC), Clinical Pathology Center (CPC), Chongqing University Three Gorges Hospital, Chongqing University, Wanzhou, Chongqing, China.
  • Liu Z; Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, China.
  • McCarthy C; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Vicencio JM; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Cao L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Alfano G; Department of Rheumatology and Immunology, Peking University People's Hospital and Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Suwaidan AA; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Yin M; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Beatson R; Clinical Research Center (CRC), Clinical Pathology Center (CPC), Chongqing University Three Gorges Hospital, Chongqing University, Wanzhou, Chongqing, China.
  • Ng T; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. r.beatson@ucl.ac.uk.
Br J Cancer ; 129(12): 1877-1892, 2023 12.
Article in En | MEDLINE | ID: mdl-37794178
ABSTRACT
Thioredoxin-interacting protein (TXNIP) is commonly considered a master regulator of cellular oxidation, regulating the expression and function of Thioredoxin (Trx). Recent work has identified that TXNIP has a far wider range of additional roles from regulating glucose and lipid metabolism, to cell cycle arrest and inflammation. Its expression is increased by stressors commonly found in neoplastic cells and the wider tumor microenvironment (TME), and, as such, TXNIP has been extensively studied in cancers. In this review, we evaluate the current literature regarding the regulation and the function of TXNIP, highlighting its emerging role in modulating signaling between different cell types within the TME. We then assess current and future translational opportunities and the associated challenges in this area. An improved understanding of the functions and mechanisms of TXNIP in cancers may enhance its suitability as a therapeutic target.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thioredoxins / Neoplasms Limits: Humans Language: En Journal: Br J Cancer Year: 2023 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thioredoxins / Neoplasms Limits: Humans Language: En Journal: Br J Cancer Year: 2023 Type: Article Affiliation country: United kingdom